Latest Financials News

Cochlear Limited reported a 4% revenue rise in FY25, driven by strong implant sales and launched the world’s first smart cochlear implant system. The company forecasts up to 17% profit growth in FY26, underpinned by innovation and expanding markets.

Cochlear Limited has announced a fully franked ordinary dividend of AUD 2.15 per share for the six months ending June 2025, payable in October with multi-currency options for shareholders.

Cochlear Limited has reported steady financial growth with a 4% rise in sales revenue and a 9% increase in underlying net profit for the fiscal year ending June 2025, maintaining its dividend payout.

HealthCo Healthcare & Wellness REIT reports FY25 results marked by suspended distributions amid Healthscope receivership, while maintaining strong portfolio fundamentals and active tenant resolution efforts.

HealthCo Healthcare & Wellness REIT posted solid FY25 financials amid ongoing tenant transition challenges with Healthscope. The REIT is proactively securing alternative tenants while maintaining a robust balance sheet.

HealthCo Healthcare and Wellness REIT reported a substantial $89.3 million loss for FY25, driven by tenant payment issues and portfolio downsizing, leading to suspended distributions and a debt facility extension.

My Rewards International is seeking shareholder approval to convert $2.2 million of debt into equity and launch a $3.98 million entitlement offer, key steps toward regaining its ASX listing.

Platinum Capital Limited has received a non-binding proposal from Wilson Asset Management to take over its investment management, signaling a potential strategic shift pending shareholder approval.

Ampol Limited has announced a proposed $1.1 billion acquisition of EG Group Australia, significantly expanding its retail network and accelerating its U-GO brand rollout. The deal promises strong earnings accretion and cost synergies, pending regulatory approval.

Ampol has agreed to acquire EG Australia for $1.1 billion, significantly expanding its retail footprint and accelerating its convenience retail strategy. The deal promises strong financial returns and awaits regulatory approval.

Phoslock Environmental Technologies prepares for ASX reinstatement with improved sales, factory refurbishment, and ongoing legal mediation.

ECP Emerging Growth Limited reported a net loss for FY2025, with portfolio returns lagging the ASX Small Ordinaries Index, yet the company maintains confidence in its long-term strategy and declared a fully franked dividend.